Pharminent

Pieris teams up with AstraZeneca on respiratory drug development

The collaboration with the British pharma is Pieris’ second alliance signed this year, part of a push to accelerate development of the biotech’s platform technology. http://www.biopharmadive.com/news/pieris-astrazeneca-collaboration-respiratory-anticalin/441851/

Filed under: Respiratory